2025 Approvals & Highlights
1 h 49 min
Charles Rudin
Memorial Sloan Kettering Cancer Center, New York
Dr. Charles Rudin is Director of Memorial Sloan Kettering Cancer Center in New York, where he previously served a decade as Chief of the Thoracic Oncology Service. His research focuses on the molecular biology and treatment of lung cancer, with particular emphasis on small-cell lung cancer (SCLC). He has led multiple practice-changing trials in SCLC and NSCLC and is widely recognized for his work on tumor heterogeneity and targeted-therapy resistance mechanisms.
Connect
Charles Rudin
Featured in
Dec
18
2025
Sep
20
2024
OncoNews
Bridging The Gap In Thoracic Oncology: What To Expect From The 6th ILCS
[et_pb_section fb_built ="1" admin_label ="section" _builder_version ="4.27.4" background_color ="#f5f8fb" positioning ="none" z_index ="0" custom_padding ="0px||0px|||" global_colors_info ="{}" theme_builder_area ="post_content"][et_pb_row admin_label ="row" _builder_version ="4.27.4" background_size ="initial" background_position ="top_left" background_repeat ="repeat" width...
